Stayble Therapeutics AB
SE0013513652 · FIRST NORTH SWEDEN
4 directors and managers of Stayble Therapeutics AB have disclosed 12 transactions under MAR Article 19: 11 buys worth €33k and 1 sell worth €124k, which reads as net buying. The most recent disclosed transaction was on 2024-12-06. The largest buy was Andreas Gerward (Chief Executive Officer (CEO)/Managing Directory) for €6k. See live cluster buys or start a free 14-day trial to get alerts when Stayble Therapeutics AB insiders trade.
Insiders
4
Net flow
€-91k
Bought
€33k
Sold
€124k
Buy Stayble Therapeutics AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2024-12-06 1y ago | BUY | Andreas Gerward Chief Executive Officer (CEO)/Managing Directory | 40,000 | €0.04 | €2k |
| 2024-06-12 2y ago | BUY | Thomas Pålsson closely associated (Yes) | 32,000 | €0.03 | €891 |
| 2024-06-12 2y ago | BUY | Andreas Gerward Chief Executive Officer (CEO)/Managing Directory | 160,000 | €0.03 | €4k |
| 2023-12-08 2y ago | BUY | Thomas Pålsson closely associated (Yes) | 50,000 | €0.02 | €1k |
| 2023-07-14 3y ago | BUY | Thomas Pålsson closely associated (Yes) | 5,000 | €0.17 | €835 |
| 2023-05-24 3y ago | BUY | Thomas Pålsson closely associated (Yes) | 30,000 | €0.11 | €3k |
| 2022-08-31 4y ago | BUY | Andreas Gerward Chief Executive Officer (CEO)/Managing Directory | 15,000 | €0.43 | €6k |
| 2021-09-09 5y ago | BUY | Thomas Pålsson closely associated (Yes) | 1,000 | €0.73 | €727 |
| 2021-08-27 5y ago | BUY | Sara Charlotta Richardson Other senior executive | 6,785 | €0.75 | €5k |
| 2021-08-20 5y ago | BUY | Sara Charlotta Richardson Other senior executive | 8,215 | €0.74 | €6k |
| 2021-06-09 5y ago | BUY | Thomas Pålsson closely associated (Yes) | 4,000 | €0.65 | €3k |
| 2021-04-08 5y ago | SELL | Kjell Olmarker Member of the Board of Directors | 200,000 | €0.62 | €124k |